North America: Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Tennessee’s FAIR Rx Act Marks A Major Escalation In State PBM Reform

Tennessee's new FAIR Rx Act takes direct aim at vertical integration in the pharmacy market by prohibiting entities from simultaneously owning pharmacies, PBMs, and health insurers.

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Decentralized Clinical Trials: Key Sponsor Considerations Under FDA And EMA Guidance

The FDA and the European Medicines Agency (EMA) (jointly with the European Commission and Heads of Medicines Agencies) each have issued or updated their respective guidance addressing decentralized clinical trial...

United States Healthcare

CM

Crowell & Moring LLP

Critical Considerations For AI Model Licensing Agreements In Healthcare

AI licensing in healthcare involves complex decisions about asset definition, control allocation, and accountability as models and data evolve. This white paper examines the practical contracting challenges that arise when AI models intersect with health data, exploring how organizations can structure agreements that account for messy datasets, model artifacts, and the reality that machine learning systems resist traditional ownership frameworks.

United States Healthcare

FH

Foley Hoag LLP

Virtual & Digital Health Digest

This digest covers key virtual and digital health regulatory and public policy developments during March and early April 2026 from the United States, United Kingdom, and European Union.

United States Healthcare

AP

Arnold & Porter

FinCEN Raises Alarm On Healthcare Fraud

United States Healthcare

AP

Arnold & Porter

AbbVie Regulatory Submission And Deal News

United States Healthcare

GP

Goodwin Procter LLP

Seventh Circuit Reins In BIPA Exposure

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

Peptides At The Crossroads: FDA Tightens The Line As Category 2 Pushes Toward Category 1

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

What FDA’s Latest Peptide Action Really Means For Compounding Pharmacies

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

AI Regulation: The New Compliance Frontier

United States Healthcare

HK

Holland & Knight

FDA Turns Up The Heat On GLP 1 Dupes Sold “For Research Use Only,” Finds Intended Use Suggests Otherwise (Podcast)

United States Healthcare

KD

Kelley Drye & Warren LLP

Introducing The Healthcare Class Action Review – 2026: A Deep Dive Into Healthcare Litigation Trends

United States Healthcare

DM

Duane Morris LLP

FDA Makes Moves To Modernize Drug Development, Clinical Trial Paradigm

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

Les aspects réglementaires et liés à la propriété intellectuelle encadrant les médicaments vétérinaires au Canada

Canada Healthcare

SB

Smart & Biggar

What Europe's Renewable Energy Struggles Can Teach U.S. Regulators About Dispute System Design

United States Litigation

J

JAMS

Colorado "Opt-Out" Litigation – Petition For Rehearing En Banc And Amicus Briefs In Support

United States Finance

BS

Ballard Spahr LLP

401(k) And IRA Contribution Limits For 2026: Retirement Savings, Adjustments For Inflation, And SECURE 2.0 Changes American Taxpayers Must Know About

United States Tax

RS

Rotfleisch & Samulovitch P.C.

Kentucky General Assembly Lends Support For Nuclear Development With Senate Bill 57

United States Energy

FB

FBT Gibbons

Littler Lounge: Just Cause For A Chat About Corrective Actions (Podcast)

United States Employment

LM

Littler Mendelson

See more

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Life Sciences, Biotechnology & Nanotechnology

Are Skinny Labels Getting Heavier For Generics? Key Takeaways From Hikma v. Amarin, The Supreme Court's First Patent Case Since 2023

As prescription drug prices continue to soar in the United States, the Supreme Court recently heard the highly anticipated oral arguments in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.

United States IP

CM

Crowell & Moring LLP

Review Of Recent EPO Decisions On Polymorphs

The European Patent Office (EPO) has established a fairly consistent and settled approach to the patentability of crystalline polymorphs of small molecule pharmaceuticals: it is generally required...

United States IP

JA

J A Kemp LLP

Decentralized Clinical Trials: Key Sponsor Considerations Under FDA And EMA Guidance

The FDA and the European Medicines Agency (EMA) (jointly with the European Commission and Heads of Medicines Agencies) each have issued or updated their respective guidance addressing decentralized clinical trial...

United States Healthcare

CM

Crowell & Moring LLP

Discounts? For Spring? Groundbreaking

United States Finance

SR

McDermott Will & Schulte

DOJ Civil Division Launches ‘FOCUS’ Initiative To Enhance Partnerships With 'Data-Miner' Whistleblowers

United States Government

AG

Akin Gump Strauss Hauer & Feld LLP

Critical Considerations For AI Model Licensing Agreements In Healthcare

United States Healthcare

FH

Foley Hoag LLP

AbbVie Regulatory Submission And Deal News

United States Healthcare

GP

Goodwin Procter LLP

Virtual & Digital Health Digest

United States Healthcare

AP

Arnold & Porter

FDA Makes Moves To Modernize Drug Development, Clinical Trial Paradigm

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

See more

Food and Drugs Law

Are Skinny Labels Getting Heavier For Generics? Key Takeaways From Hikma v. Amarin, The Supreme Court's First Patent Case Since 2023

As prescription drug prices continue to soar in the United States, the Supreme Court recently heard the highly anticipated oral arguments in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.

United States IP

CM

Crowell & Moring LLP

Review Of Recent EPO Decisions On Polymorphs

The European Patent Office (EPO) has established a fairly consistent and settled approach to the patentability of crystalline polymorphs of small molecule pharmaceuticals: it is generally required...

United States IP

JA

J A Kemp LLP

Supreme Court Grapples With Roundup®, Federal Preemption, And The Limits Of EPA Authority

On April 27, 2026, the U.S. Supreme Court heard oral argument in Monsanto Company v. Durnell, a closely watched case that could reshape the intersection of federal pesticide...

United States Litigation

BC

Bergeson & Campbell

Tennessee’s FAIR Rx Act Marks A Major Escalation In State PBM Reform

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Maryland Enacts Food-Sector Personalized Pricing Law

United States Consumer

GT

Greenberg Traurig, LLP

Decentralized Clinical Trials: Key Sponsor Considerations Under FDA And EMA Guidance

United States Healthcare

CM

Crowell & Moring LLP

DEA Final Order Creates Federal Pathway For Medical Marijuana

United States Cannabis

DW

Dickinson Wright PLLC

Virtual & Digital Health Digest

United States Healthcare

AP

Arnold & Porter

Les aspects réglementaires et liés à la propriété intellectuelle encadrant les médicaments vétérinaires au Canada

Canada Healthcare

SB

Smart & Biggar

See more

Healthcare

PepsiCo, ERISA Litigation, And Modification To Retiree Health Benefits Programs: What Employers Need To Know

Public records indicate that PepsiCo, Inc., may have settled an Employee Retirement Income Security Act (ERISA) challenge to its ability to change the terms of its retiree health benefits program.

United States Employment

HB

Hall Benefits Law

Tennessee’s FAIR Rx Act Marks A Major Escalation In State PBM Reform

Tennessee's new FAIR Rx Act takes direct aim at vertical integration in the pharmacy market by prohibiting entities from simultaneously owning pharmacies, PBMs, and health insurers.

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Decentralized Clinical Trials: Key Sponsor Considerations Under FDA And EMA Guidance

The FDA and the European Medicines Agency (EMA) (jointly with the European Commission and Heads of Medicines Agencies) each have issued or updated their respective guidance addressing decentralized clinical trial...

United States Healthcare

CM

Crowell & Moring LLP

Critical Considerations For AI Model Licensing Agreements In Healthcare

United States Healthcare

FH

Foley Hoag LLP

Discounts? For Spring? Groundbreaking

United States Finance

SR

McDermott Will & Schulte

The New York Appellate Division’s First PSQIA Decision Denies Privilege Protection

United States Litigation

WE

Wilson Elser Moskowitz Edelman & Dicker LLP

Virtual & Digital Health Digest

United States Healthcare

AP

Arnold & Porter

Emerging Alternatives For GLP-1 Prescription Drug Coverage: What Plan Sponsors Need To Know

United States Employment

BB

Bass, Berry & Sims

Benefits Counselor – April 2026

United States Employment

RB

Reinhart Boerner Van Deuren s.c.

See more

Latest Videos

See more

No Foolin’: Business In 2026 Webinar Gets An April Makeover (Video)

BS

Bond, Schoeneck & King PLLC

PBM Reform 2026: What Recent Legislation Means For The Industry (Video)

M

Mintz

In The Know: The Clean Beauty Trend Becomes State Law (Video)

LL

Loeb & Loeb LLP

GT Legal Food Talk Episode 30: Navigating Liquor Licensing: Inside The Legal Food & Beverage Landscape (Podcast)

GT

Greenberg Traurig, LLP

Leaders In Law: Life Sciences And Technology Transactions With Jekkie Kim (Podcast)

W

WilmerHale

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More